Skip to Main Content
Table 1—

Clinical characteristics of the AdRem study population and the main ADVANCE study

AdRemADVANCE
n 1,605 11,140 
Female sex (%) 38.6 42.5 
Age (years) 65.6 ± 5.8 65.8 ± 6.4 
Current smoking (%) 15.8 15.1 
Ethnicity (%)   
    Caucasian 48 60.0 
    Chinese 38 30.1 
    South Asian 11 7.9 
    Other 
Duration diabetes (years) 7.3 ± 6.1 7.9 ± 6.4 
A1C (%) 7.4 ± 1.5 7.5 ± 1.6 
Diabetes treatment (%)   
    Dietician 36 35 
    Oral glucose-lowering medication 89 91 
        1 drug 43 43 
        2 drugs 39 42 
        ≥3 drugs 
    Insulin 
Blood pressure (mmHg) 136/77 ± 21/11 145/81 ± 22/11 
Blood pressure lowering medication 70 75 
AdRemADVANCE
n 1,605 11,140 
Female sex (%) 38.6 42.5 
Age (years) 65.6 ± 5.8 65.8 ± 6.4 
Current smoking (%) 15.8 15.1 
Ethnicity (%)   
    Caucasian 48 60.0 
    Chinese 38 30.1 
    South Asian 11 7.9 
    Other 
Duration diabetes (years) 7.3 ± 6.1 7.9 ± 6.4 
A1C (%) 7.4 ± 1.5 7.5 ± 1.6 
Diabetes treatment (%)   
    Dietician 36 35 
    Oral glucose-lowering medication 89 91 
        1 drug 43 43 
        2 drugs 39 42 
        ≥3 drugs 
    Insulin 
Blood pressure (mmHg) 136/77 ± 21/11 145/81 ± 22/11 
Blood pressure lowering medication 70 75 

Data are means ± SD or %.

Close Modal

or Create an Account

Close Modal
Close Modal